Caplacizumab
(Unterschied zwischen Versionen)
Ossip Groth (Diskussion | Beiträge)
(Die Seite wurde neu angelegt: „Caplacizumab is a therapeutic monoclonam antibody which interferes with bindung of platelets to extralong vWF multimers. It is first-line acute treatment optio…“)
Zum nächsten Versionsunterschied →
(Die Seite wurde neu angelegt: „Caplacizumab is a therapeutic monoclonam antibody which interferes with bindung of platelets to extralong vWF multimers. It is first-line acute treatment optio…“)
Zum nächsten Versionsunterschied →
Version vom 3. Oktober 2020, 20:07 Uhr
Caplacizumab is a therapeutic monoclonam antibody which interferes with bindung of platelets to extralong vWF multimers. It is first-line acute treatment option of TTP thrombotic thrombocytopenic purpura. I heard a talk at dgfn2020 and decided to aks the open question, might it be useful for coid19. 3 min answer :))))
Nothing at pubmed, some at pmc by full-text cooccurence of phrases, e.g.
32454092 2020. Microvascular thrombosis: experimental and clinical implications |